Search
Mckesson Corp
MCKAdd to Watchlist
745.185USD
-5.445-0.73%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
89.42BMarket Cap
19.34P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.73%
5 Days
-4.44%
1 Month
-2.73%
6 Months
-8.95%
Year to Date
-9.16%
1 Year
+3.37%
Key Figures
751.550Open
757.180High
1.45MVolume
19.34P/E TTM
17.15P/E Dynamic
3.170Dividend TTM
1.21%Turnover Ratio
750.630Prev. Close
744.450Low
530.20MTurnover
27.14P/E Static
-41.17P/B
0.43%Div Yield TTM
6.48%ROA
999.00052wk High
1.29Volume Ratio
3.29BNet Profit
120.00MShares
38.5275EPS TTM
0.33Beta
--ROE
637.00052wk Low
1.70%Amplitude
4.20%Gross Margin
89.42BMarket Cap
-1.39Reward/Risk
1.49%Risk Rate
TradingKey Stock Score of Mckesson Corp
Currency: USD Updated: 2026-06-22Key Insights
Mckesson Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 6 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 932.82.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Mckesson Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
38°C
Very Low
Very High
Negative
Mckesson Corp Highlights
StrengthsRisks
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 403.43B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 30.58% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 403.43B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 10.68%.
Undervalued
The company’s latest PE is 19.33, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 112.82M shares, decreasing 2.46% quarter-over-quarter.
Held by Steve Mandel
Star Investor Steve Mandel holds 448.68K shares of this stock.
Analyst Rating
Based on
19
analysts
Buy
Current Rating
932.815
Target Price
+24.27%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Mckesson Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Mckesson Corp Info
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
Ticker SymbolMCK
CompanyMckesson Corp
CEOTyler (Brian Scott)
Websitehttps://www.mckesson.com/
Related Instruments
+0.50%
+1.28%
+0.83%
+6.26%
+1.27%
+1.42%
+2.11%
+0.90%
+6.27%
-0.54%
+3.36%
+1.30%
+0.14%
-1.38%
0.00%
+0.41%
+2.98%
+0.40%
-1.09%Popular Instruments
73.647
-0.342 (-0.46%)
297.230
-0.780 (-0.26%)
208.780
-1.910 (-0.91%)
4127.470
-62.780 (-1.50%)
732.810
-13.420 (-1.80%)
2273.370
+88.620 (+4.06%)
1213.000
+79.010 (+6.97%)
349.710
-18.320 (-4.98%)
63585.810
-817.990 (-1.27%)
404.920
+4.430 (+1.11%)
FAQs
What is the current price of Mckesson Corp (MCK)?
The current price of Mckesson Corp (MCK) is 745.18.
What is the symbol of Mckesson Corp?
The ticker symbol of Mckesson Corp is MCK.
What is the 52-week high of Mckesson Corp?
The 52-week high of Mckesson Corp is 999.00.
What is the 52-week low of Mckesson Corp?
The 52-week low of Mckesson Corp is 637.00.
What is the market capitalization of Mckesson Corp?
The market capitalization of Mckesson Corp is 89.42B.
Is Mckesson Corp (MCK) currently rated as Buy, Hold, or Sell?
According to analysts, Mckesson Corp (MCK) has an overall rating of Buy, with a price target of 932.82.
What is the Earnings Per Share (EPS TTM) of Mckesson Corp (MCK)?
The Earnings Per Share (EPS TTM) of Mckesson Corp (MCK) is 38.53.
